{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:30:48Z","timestamp":1789047048916,"version":"build-2803163510"},"reference-count":0,"publisher":"Dustri-Verlag Dr. Karl Feistle","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.5414\/cp204936","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:32:10Z","timestamp":1789043530000},"source":"Crossref","is-referenced-by-count":0,"title":["Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients"],"prefix":"10.5414","author":[{"given":"Lingyan","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:32:11Z","timestamp":1789043531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dustri.com\/index.php?id=8&artId=193205&doi=10.5414\/CP204936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":0,"alternative-id":["204936"],"URL":"https:\/\/doi.org\/10.5414\/cp204936","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}